Ledger.Open graph →
SEC Form D · filed June 9, 2020

Novo Biosciences, Inc

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Lamoine, ME
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Viravuth Yin · Trenton, MEExec · DirectorKevin Strange · Bar Harbor, MEExec · DirectorViravuth Yin · Trenton, MEExec · DirectorKevin Strange · Bar Harbor, MEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗